RB1 and breast carcinoma: Based on our findings that all three point mutated pRb proteins expressed reduced pro-apoptotic effect in vitro, and three out of four tumors harboring RB1 mutations were resistant to chemotherapy, our data provide the first indication that RB1 alterations could influence breast cancer chemosensitivity in vivo.